Revision history of "Increase the attractiveness and market value of the drug candidate OATD-01 by preparing to submit to the European Medicines Agency an application for orphan drug status in the treatment of rare respiratory diseases that are unmet medical needs in the worl" (Q108512)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 06:1306:13, 9 October 2024DG Regio talk contribs 92,055 bytes −28 Changed label, description and/or aliases in pt
  • curprev 06:1306:13, 9 October 2024DG Regio talk contribs 92,083 bytes −20 Set a claim value: summary (P836): O principal objetivo do projeto é desenvolver o pedido de estatuto de medicamento órfão e desenvolvê-lo de acordo com os requisitos da Agência Europeia de Medicamentos, para que o candidato ao medicamento, a molécula OATD-01, seja utilizado como comprimido uma vez por dia. A obtenção do estatuto de medicamento órfão é um marco importante para a OncoArendi Therapeutics SA no desenvolvimento de um candidato a medicamento inovador. Não só facultará o a...

22 March 2024

15 January 2024

12 June 2023

24 May 2023

2 March 2023

  • curprev 19:2519:25, 2 March 2023DG Regio talk contribs 89,345 bytes +526 Changed label, description and/or aliases in it, lv, da, sk, ro, es, ga, fi, el, fr, sv, lt, et, hr, nl, hu, pt, bg, sl, cs, mt, de, and other parts

23 October 2022

2 July 2022

  • curprev 14:1014:10, 2 July 2022DG Regio talk contribs 88,005 bytes +56,560 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 10:1310:13, 1 December 2021DG Regio talk contribs 18,441 bytes +2,938 Created claim: summary (P836): L’objectif principal du projet est de développer une demande de statut orphelin et de la développer conformément aux exigences de l’Agence européenne des médicaments, pour que le candidat médicamenteux, la molécule OATD-01, soit utilisé comme comprimé une fois par jour. Obtenir un statut de médicament orphelin est une étape importante pour OncoArendi Therapeutics SA dans le processus de développement d’un médicament candidat innovant. Non seulem...
  • curprev 10:1310:13, 1 December 2021DG Regio talk contribs 15,503 bytes +365 Changed label, description and/or aliases in fr: translated_label

29 October 2020

20 October 2020

  • curprev 10:4310:43, 20 October 2020DG Regio talk contribs 15,579 bytes +318 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 10:4310:43, 20 October 2020DG Regio talk contribs 15,261 bytes −306 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 10:4310:43, 20 October 2020DG Regio talk contribs 15,567 bytes +2,649 Created claim: summary (P836): The main objective of the project is to develop the application for orphan drug status and to develop it in accordance with the requirements of the European Medicines Agency, for the candidate for the drug, the OATD-01 molecule, to be used as a tablet once a day. Obtaining orphan drug status is an important milestone for OncoArendi Therapeutics SA in the development of an innovative drug candidate. Not only will it provide access to the support...
  • curprev 10:4310:43, 20 October 2020DG Regio talk contribs 12,918 bytes −2,306 Removed claim: summary (P836): The main objective of the project is to develop an application for an orphan medicine status and to develop it in accordance with the requirements of the European Medicines Agency for the candidate for the medicine, the OATD-01 molecule, to be used in the form of a daily tablet. Obtaining an orphan medicine status is an important milestone in the process of developing a candidate for an innovative medicine. It will not only ensure access to th...

24 September 2020

16 July 2020

22 June 2020

10 June 2020

6 June 2020

26 March 2020

9 March 2020

  • curprev 09:4909:49, 9 March 2020DG Regio talk contribs 13,500 bytes +2,306 Created claim: summary (P836): The main objective of the project is to develop an application for an orphan medicine status and to develop it in accordance with the requirements of the European Medicines Agency for the candidate for the medicine, the OATD-01 molecule, to be used in the form of a daily tablet. Obtaining an orphan medicine status is an important milestone in the process of developing a candidate for an innovative medicine. It will not only ensure access to the...

24 February 2020

18 February 2020

31 January 2020

14 January 2020